Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Unilife Corp (UNIS)
|
Add to portfolio |
|
|
|
| Price: |
$0.16
| | Metrics |
| OS: |
18.1
|
M
| |
|
|
| Market cap: |
$2.89
|
M
| |
-152
|
% ROIC
|
|
Net debt:
|
$117
|
M
| |
|
|
|
EV:
|
$120
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($57.4)
|
M
| |
|
|
|
EBIT
|
($62.6)
|
M
| |
|
|
| EPS |
($5.22)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Jun-30-16 | Jun-30-15 | Jun-30-14 | Jun-30-13 | Jun-30-12 | Jun-30-11 | Jun-30-10 | Jun-30-09 |
| Revenues | 14.8 | 13.2 | 14.7 | 2.7 | 5.5 | 1.4 | 11.4 | 20.0 |
| Revenue growth | 12.8% | -10.4% | 435.5% | -50.3% | 308.8% | -88.2% | -42.8% | 470.7% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.1 | 0.6 | 2.6 | 2.5 | 3.4 |
| Gross profit | 14.8 | 13.2 | 14.7 | 2.6 | 4.9 | -1.2 | 9.0 | 16.6 |
| Gross margin | 100.0% | 100.0% | 100.0% | 95.3% | 89.4% | -92.4% | 78.4% | 82.8% |
| Selling, general and administrative | 43.2 | 36.2 | 27.9 | 32.4 | 27.7 | 45.2 | 26.3 | 13.8 |
| Research and development | 43.2 | 52.5 | 34.1 | 21.7 | 23.1 | | 10.9 | 2.2 |
| EBIT | -77.0 | -80.4 | -51.4 | -61.1 | -50.5 | -46.5 | -30.6 | -0.4 |
| EBIT margin | -519.1% | -611.2% | -349.9% | -2226.0% | -914.5% | -3441.3% | -267.5% | -1.8% |
| Pre-tax income | -100.8 | -90.8 | -57.9 | -63.2 | -52.3 | 0.0 | -29.7 | -0.5 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | | 0.0% | 0.0% |
| Net income | -100.8 | -90.8 | -57.9 | -63.2 | -52.3 | 0.0 | -29.7 | -0.5 |
| Net margin | -679.1% | -690.4% | -394.2% | -2304.0% | -947.7% | 0.0% | -260.4% | -2.6% |
| |
| Diluted EPS | ($6.97) | ($8.10) | ($5.90) | ($7.79) | ($0.78) | $0.00 | ($0.64) | ($0.02) |
| Shares outstanding (diluted) | 14.5 | 11.2 | 9.8 | 8.1 | 67.4 | 57.9 | 46.8 | 25.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|